Sudeep Pharma Submits 37th Annual Report, Sets AGM for Aug 4, 2026

Sudeep Pharma Ltd has submitted its 37th Annual Report for the Financial Year 2025-26. The report details the company's performance, strategic priorities, and expansion into next-generation energy solutions, particularly battery materials through its subsidiary Sudeep Advanced Materials (SAMPL). The Annual General Meeting (AGM) is scheduled for Tuesday, August 4, 2026, at 11:00 A.M. via Video Conferencing. The report highlights a market capitalization of ₹6,693 crore as of March 31, 2026, and a final dividend of ₹1.50 per share. The company emphasizes its journey from mineral excipients for nutrition and pharmaceuticals to advanced materials for electric vehicles and energy storage.